Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Lung Cancer
>
>
7
Volume:
7
1. Dynamic enhanced multi-slice spiral CT in evaluation of blood flow patterns of solitary pulmonary nodules with enhancement.
Page:520—525
2. Clinical study of navelbine combined with cisplatin in the treatment of advanced non-small cell lung cancer.
Page:517—519
3. Diagnosis and treatment of pulmonary sclerosing hemangioma.
Page:515—516
4. Clinical analysis of 99 young patients with lung cancer in different nationalities in Xinjiang.
Page:512—514
5. Clinical analysis on characteristics of lymph node metastasis in lung cancer.
Page:508—511
6. Efficacy of MVP chemotherapy combined with concurrent radiotherapy for advanced non-small cell lung cancer.
Page:505—507
7. Study of COX-2 expression and angiogenesis in non-small cell lung cancer.
Page:501—504
8. Expression of MMP-2, MMP-9, TIMP-1 and their relationship with prognosis in NSCLC.
Page:497—500
9. Expression of Skp2 and its correlation with c-myc in non-small cell lung cancer.
Page:493—496
10. Expression of vascular endothelial growth factor C and its receptor VEGF-R3 and their significance in non-small cell lung cancer.
Page:488—492
11. The clinical significance of thymosin β4 expression in human non-small cell lung cancer.
Page:483—487
12. Experimental study on the chemosensitivity of peripheral blood lymphocytes and tumor cells of lung cancer in vitro.
Page:480—482
13. Cloning of human telomerase catalytic subunit gene promoter and studying on its specific transcriptional activities in human lung cancer cells.
Page:475—479
14. Effects of transfection of nm23-H1 gene on β-catenin expression in human high-metastatic large cell lung cancer cell line L9981.
Page:471—474
15. Experimental study on lung cancer-targeted oncostatin M gene therapy induced by ionizing radiation.
Page:467—470
16. Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer.
Page:449—451
17. Analysis of three-dimensional conformal radiotherapy for elderly patients with stage I-III non-small cell lung cancer: results of 30 cases.
Page:446—448
18. Clinical observation of gemcitabine and concurrent three-dimensional conformal radiotherapy (3D-CRT) in the treatment of locally advanced non-small cell lung cancer.
Page:442—445
19. Clinical analysis of the characteristics of thoracic lymph node metastasis in lung cancer: A report of 318 cases.
Page:438—441
20. Resection and reconstruction of carina in the treatment of advanced lung cancer involving carina.
Page:434—437
21. Surgical treatment of lung cancer by video-assisted thoracoscopic surgery.
Page:431—433
22. The clinical significance of detection of vascular endothelial growth factor and CD44v6 expression in human non-small cell lung cancer.
Page:427—430
23. The influence of cryosurgery on great vessels and heart in patients with lung cancer.
Page:423—426
24. Study on relationship between p63 expression and 3q27-q29 alteration in non-small cell lung cancer.
Page:419—422
25. Expression of fas and P53 protein in resected non-small cell lung cancer and its prognostic significance.
Page:414—418
26. Expression and mutation of β-catenin in non-small cell lung cancer.
Page:409—413
27. Relationship between protein kinase CβI(PKC-βI) expression, apoptosis and prognosis in patients with non-small cell lung cancer.
Page:404—408
28. Guideline of surgical practice for non-small cell lung cancer based staging.
Page:399—403
29. Effects of photodynamic therapy on human lung adenocarcinoma cell line A549.
Page:396—398
30. Overexpression of p73 gene inhibits VEGF and bFGF mRNA expression in lung adenocarcinoma cell.
Page:392—395
31. Inhibitive effect of LAK cells induced by dendritic cells on implanted lung cancer in nude mice.
Page:387—391
32. Expression of SOCS3 gene and its effect on cell proliferation in human lung adenocarcinoma cell line A549.
Page:383—386
33. The anti-lung cancer activity of a modified HPV 16 type mE6Δ/mE7 fusion protein based vaccine in an experimental animal model.
Page:379—382
34. Clinical study on the metastatic patterns of lymph node in lung cancer.
Page:361—363
35. Long-term consecutive follow-up of high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation (APBSCT) in the treatment of small cell lung cancer.
Page:357—360
36. Comparative study of sputum sediment paraffin section and sputum smear examinations for diagnosis of lung cancer.
Page:354—356
37. Sequential variation of pulmonary flow spectrum and its value on the evaluation of risk for pulmonary resection in perioperative patients with lung cancer.
Page:351—353
38. Thoracoscopy and thoracotomy for lung biopsy and wedge resection in solitary pulmonary nodule.
Page:347—350
39. Expression of hypoxia inducible factor 1α and its clinical significance in non-small cell lung cancer.
Page:344—346
40. Different expressions of p53 gene family members and their clinical significance in human non-small cell lung cancer.
Page:339—343
41. Relationship of cytokine level with cancer cachexia and therapeutic effects of indomethacin for cancer cachexia.
Page:336—338
42. Effect of exogenous p73 gene on chemosensitivity of wild-type p53 human lung adenocarcinoma cell A549.
Page:331—335
43. Targeted Iressa therapy in patients with brain metastases from non-small cell lung cancer.
Page:329—330
44. Phase II clinical trial of homemade human rh-endostatin in the treatment of patients with stage IIIB-IV non-small cell lung cancer.
Page:325—328
45. Iressa for the non-small cell lung cancer patients who failed prior chemotherapy and radiotherapy.
Page:321—324
46. Gefitinib molecular target therapy for Chinese patients with non-small cell lung cancer.
Page:318—320
47. The salvage regimen for patients with advanced non-small cell lung cancer who failed prior chemotherapy: once-daily single oral agent Iressa.
Page:313—317
48. ZD1839 (Iressa) in the treatment of non-small cell lung cancer patients.
Page:309—312
49. Iressa for refractory non-small cell lung cancer: A preliminary report.
Page:305—308
50. Gefitinib is active in patients with brain metastasis from non-small cell lung cancer.
Page:298—304
51. Targeting blockage of Wnt signal transduction pathway of nm23-H1 gene transfection in human high-metastatic large cell lung cancer cell line L9981.
Page:294—297
52. Experimental study of tissue-specific suicide gene therapy for lung adenocarcinoma.
Page:290—293
53. Targeted therapy in non-small cell lung cancer.
Page:284—289
54. A new horizon of targeted therapy in management of lung cancer.
Page:276—283
55. Trend of molecular target therapy of non-small cell lung cancer.
Page:270—275
56. More attention should be devoted to molecular target therapy of lung cancer in our country.
Page:267—269
57. A randomized clinical study on efficacy of Aidi injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer.
Page:247—249
58. A randomized clinical trial of cisplatin solution and cisplatin powder combination regimens in the treatment of patients with lung cancer.
Page:243—246
59. Randomized clinical trial of IEP and EP regimens in the treatment of patients with small cell lung cancer.
Page:240—242
60. Clinical study of combined chemotherapy of domestic paclitaxel and vinorelbine plus platinum for advanced non-small cell lung cancer.
Page:236—239
61. Factors affecting the quality of life in lung cancer patients measured by EORTC QLQ questionnaire.
Page:230—235
62. Detection of CK19 and CEA mRNA expression for the diagnosis of peripheral blood micrometastases in patients with non-small cell lung cancer.
Page:226—229
63. Analysis of seven trace element contents in benign lung tissue, lung cancer tissue and paracancerous tissue of patients with lung cancer.
Page:222—225
64. Coexpression and clinical significance of multi-drug resistance factors in lung cancer.
Page:218—221
65. The clinical significance of detection of Th1/Th2 cell cytokines in lung cancer.
Page:214—217
66. Detection of mRNA expression of CK-19 and MUC1 gene for diagnosis of lymph node micrometastasis in NSCLC patients by reverse transcriptase-polymerase chain reaction.
Page:209—213
67. Expression of c-kit protein and its significance in human small cell lung cancer.
Page:206—208
68. The diagnostic value of flow cytometric DNA analysis of sputum in lung cancer.
Page:202—205
69. Expression of aquaporins and its significance in human pulmonary adenocarcinoma cell line SPC-A-1.
Page:199—201
70. Study on the inhibitory effect of antisense PNA of telomerase for growth of lung cancer cell lines in vitro.
Page:196—198
71. Effect of cyclooxygenase-2 inhibitor, nimesulide, combined with cisplatin on lung cancer.
Page:191—195
72. Establishment of a human large cell lung cancer cell line L9981-nm23-H1.
Page:187—190
73. Combination of gemcitabine and carboplatin in the treatment of advanced non-small cell lung cancer.
Page:168—170
74. Combined chemotherapy of weekly paclitaxel and ifosfamide in the treatment of 23 patients with advanced non-small cell lung cancer.
Page:165—167
75. Relationship between micrometastasis of bone marrow and neoadjuvant chemotherapy and prognosis in patients with stage III non-small cell lung cancer.
Page:161—164
76. Detection of interleukin-10 in alveolar macrophage and peripheral blood monocyte from lung cancer patients and its clinical significance.
Page:158—160
77. Diagnostic value of multiple tumor marker protein biochip detective system for lung cancer.
Page:154—157
78. Therapeutic efficacy of chemotherapy with VIP for small cell lung cancer.
Page:151—153
79. Prognostic significance of neuroendocrine differentiation in non-small cell lung cancer patients' survival.
Page:146—150
80. Expression and clinical significance of vascular endothelial growth factor in human non-small cell lung cancer.
Page:142—145
81. Expression of survivin and its correlation with apoptosis in non-small cell lung cancer.
Page:138—141
82. Expression of phosphatase and tensin homology deleted on chromosome ten (PTEN) and FasL proteins and their significance in human small cell lung cancer.
Page:134—137
83. Effects and mechanisms of fibronectin on adhesion and migration of different types of lung cancer cell lines.
Page:130—133
84. Somatic mutation detection in complete mitochondrial DNA of lung cancer patients.
Page:125—129
85. Expression of hnRNP A2/B1 in human lung cancer cell lines.
Page:121—124
86. Expression of COX-2 and its prognostic significance in non-small cell lung cancer.
Page:118—120
87. Relationship between genetic polymorphism of metabolizing enzymes and lung cancer susceptibility.
Page:112—117
88. Regulation of nm23-H1 transfection on expression of integrins in human high-metastasis large cell lung cancer cell line L9981.
Page:108—111
89. Anti-tumor activities of lung cancer dendritic cell vaccine modified by mutant Ki-ras gene in vitro.
Page:104—107
90. The heterogeneous nuclear ribonucleoprotein A2/B1 expression in non-small cell lung cancer and its clinical significance.
Page:99—103
91. Construction of Bifidobacterium Infantis/CD tumor targeting gene therapy system.
Page:95—98
92. Experimental study of effects of nm23-H1 gene transfection on the change of PKA activity in human high-metastasis large cell lung cancer cell line L9981.
Page:91—94
93. Study on protein kinase C translocation before and after transfection of nm23-H1 gene in human lung cancer cells using Laser scanning confocal microscope.
Page:86—90
94. Transfection of tumor metastasis suppressor gene nm23-H1 can up-regulate the activity of GSK-3β in human high-metastasis large cell lung cancer cell line L9981.
Page:81—85
95. Hydroxycamptothecin-based chemotherapy combined with concurrent radiotherapy for advanced non-small cell lung cancer.
Page:67—69
96. Randomly clinical study of ITP and NP regimens in the treatment of non-small cell lung cancer.
Page:64—66
97. The value of chest CT scan and tumor markers detection in sputum for early diagnosis of peripheral lung cancer.
Page:58—63
98. The clinical investigation of extracorporeal vein bypass during lobectomy combined with superior vena cava graft for lung cancer.
Page:55—57
99. Serum levels of endostatin and VEGF in non-small cell lung cancer patients and the relationship with the clinical pathophysiological characteristics.
Page:50—54
100. The diagnostic value of determination of p16 methylation of sputum exfoliated cells for peripheral lung cancer.
Page:46—49
101. Expression of vascular endothelial growth factor and its significance in pulmonary bronchoalveolar carcinoma.
Page:43—45
102. Study on the relationship between polymorphisms of CYP1A1 gene and susceptibility of lung cancer in Sichuan population.
Page:38—42
103. Diagnostic value of determination of CEA, CA125, CA153 and CA199 assay in pleural fluid for lung cancer.
Page:35—37
104. The expression of p63 gene in human non-small cell lung cancer.
Page:31—34
105. Distribution and mRNA expression of β-catenin in non-small-cell lung cancer.
Page:27—30
106. A study on the relationship between the expression of protein kinase C βII and apoptosis in patients with non-small cell lung cancer.
Page:22—26
107. Expression of heparanase in human non-small cell lung cancer.
Page:16—21
108. Differential expression of BRI gene in human non-small cell lung cancer cells.
Page:12—15
109. Transfection of the tumor metastasis suppressor gene nm23-H1 can targetly suppress the activity of extracellular signal-regulated protein kinase (ERK) in human high-metastasis large cell lung cancer cell line L9981.
Page:8—11
110. Effects of huTNF-α and hIL-2 gene transfection on the expression of MDR1 and LRP genes in lung cancer cell lines.
Page:4—7
111. New argument for cycle of chemotherapy in advanced non-small cell lung cancer.
Page:1—3
